Real‐world data on voxelotor to treat patients with sickle cell disease-Reference-Cited by-同舟云学术

Real‐world data on voxelotor to treat patients with sickle cell disease

Published:2022-05-26 Issue:2 Volume:109 Page:154-161
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Muschick Kathryn¹,Fuqua Tranaka¹,Stoker‐Postier Carrianne¹,Anderson Alan R.¹²^ORCID

Affiliation:

1. Prisma Health–Upstate Comprehensive SCD Program Greenville South Carolina USA

2. University of South Carolina School of Medicine Greenville South Carolina USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13782

Reference10 articles.

1. Center for Disease Control and Prevention (CDC).Sickle cell disease.2020. Accessed March 23 2022.https://www.cdc.gov/ncbddd/sicklecell/data.html

2. Food and Drug Administration.The Voice of the Patient. A series of reports from the US Food and Drug Administration's Patient‐Focused Drug Development Initiative Sickle Cell Disease Public Meeting: 7 February 2014 Report Date: October 2014. U.S. Food and Drug Administration. Accessed August 03 2021.https://www.fda.gov/media/86879/download

3. Fatigue in Adolescents and Young Adults With Sickle Cell Disease

4. Bone Marrow Transplantation in Sickle Cell Anemia — The Dilemma of Choice

5. PULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to Children

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newer Modalities and Updates in the Management of Sickle Cell Disease: A Systematic Review;Journal of Blood Medicine;2024-09

2. Sickle Cell Disease;Stroke Genetics;2024

3. An expert review of voxelotor for the treatment of hemolytic anemia in patients with sickle cell disease: ‘bridging the gap between laboratory data and patient related outcomes’;Expert Review of Hematology;2023-06-22

4. Emerging Therapies and Advances in Sickle Cell Disease with a Focus on Renal Manifestations;Kidney360;2023-05-31

5. An integrated therapeutic approach to sickle cell disease management beyond infancy;American Journal of Hematology;2023-05-12